Sign Up Today and Learn More About Nocion Therapeutics Stock
Invest in or calculate the value of your shares in Nocion Therapeutics or other pre-IPO companies through EquityZen's platform.
Nocion Therapeutics Stock (NOTH)
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
About Nocion Therapeutics Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Nocion Therapeutics Press Mentions
Stay in the know about the latest news on Nocion Therapeutics
Chutes & Ladders—Scholar Rock rocks the boat with new execs
fiercebiotech • May 04, 2025
Compositions and methods for treatment of inflammatory bowel disease
patents • May 04, 2025
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
citybiz • Apr 29, 2025
Charged ion channel blockers and methods for use
patents • Feb 13, 2025
Compositions and methods for treatment of inflammatory bowel disease
patents • Feb 13, 2025
Nocion Therapeutics Management
Leadership team at Nocion Therapeutics
CSO
Jim Ellis
Co-founder
Bruce Bean
Join now and verify your accreditation status to gain access to:
- Nocion Therapeutics Current Valuation
- Nocion Therapeutics Stock Price
- Nocion Therapeutics Management
- Available deals in Nocion Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nocion Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Nocion Therapeutics Revenue and Financials
- Nocion Therapeutics Highlights
- Nocion Therapeutics Business Model
- Nocion Therapeutics Risk Factors
- Nocion Therapeutics Research Report from SACRA Research
Trading Nocion Therapeutics Stock
How to invest in Nocion Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Nocion Therapeutics through EquityZen funds. These investments are made available by existing Nocion Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nocion Therapeutics stock?
Shareholders can sell their Nocion Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
